Log in to save to my catalogue

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Mye...

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Mye...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10973895

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

About this item

Full title

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

Publisher

United States: American Medical Association

Journal title

JAMA network open, 2024-03, Vol.7 (3), p.e243854

Language

English

Formats

Publication information

Publisher

United States: American Medical Association

More information

Scope and Contents

Contents

There is substantial interest in capturing cancer treatment tolerability from the patient's perspective using patient-reported outcomes (PROs).
To examine whether a PRO question, item 5 from the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale (GP5), was associated with early treatment discontinuation (ETD) due to...

Alternative Titles

Full title

Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10973895

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10973895

Other Identifiers

ISSN

2574-3805

E-ISSN

2574-3805

DOI

10.1001/jamanetworkopen.2024.3854

How to access this item